Infective endocarditis of intracardiac devices: problems of diagnosis and treatment

   The use of implantable intracardiac devices (ICD) has increased significantly over the past few decades. The incidence of ICD-associated infections has increased disproportionally to the increase in the number of device implantations. As with other forms of infective endocarditis, microbiological testing of blood for sterility and echocardiographic (ECHO) examination are the basis for diagnosing ICD infection. Positive blood culture and clinical signs remain key to diagnosing infective endocarditis, which is currently characterized by an erased, low-symptom clinical picture, and sometimes a completely asymptomatic course. In this regard, the search for “silent” forms of vascular and immunological phenomena using modern diagnostic methods (18F-fluorodeoxyglucose positron emission tomography/computed tomography) is of particular importance. However, the use of these methods in routine practice is limited. That is why a carefully collected anamnesis with a special emphasis on the search for cardiological problems, identification of predisposing social factors and pathology of internal organs is of great importance. A clinical case is presented, the peculiarity of which is the recurrent course of the disease with the formation of complications characteristic of infective endocarditis - embolic syndrome, development of acute kidney injury, decompensation of chronic heart failure. Considering the negative results of the analysis of microbiological blood tests at all stages of the recurrent course of the disease, the diagnosis was determined on the basis of echocardiography/transesophageal echocardiography and the clinical picture of the disease.

1. Voigt A., Shalaby A., Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin. Electro-physiol. 2010;33(4):414–419. doi: 10.1111/j.1540-8159.2009.02569.x

2. Dvoretsky L.I., Vakolyuk R.M., Kaptaeva A.K., Doroshchuk S.A. Infection associated with the implantation of cardiovascular implantable electronic devices. Arkhiv vnutrnney meditsiny = Archive of Internal Medicine. 2017;7(3):233–240. [In Russian]. doi: 10.20514/2226-6704-2017-7-3-233-240

3. Mahmood M., Kendi A.T., Farid S., Ajmal S., Johnson G.B., Baddour L.M., Chareonthaitawee P., Friedman P.A., Sohail M.R. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J. Nucl. Cardiol. 2019;26(3):958–970. doi: 10.1007/s12350-017-1063-0

4. Athan E., Chu V.H., Tattevin P., Selton-Suty C., Jones P., Naber C., Miró J.M., Ninot S., Fernández-Hidalgo N., Durante-Mangoni E., … Wang A. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307(16):1727–1735. doi: 10.1001/jama.2012.497

5. Le K.Y., Sohail M.R., Friedman P.A., Uslan D.Z., Cha S.S., Hayes D.L., Wilson W.R., Steckelberg J.M., Baddour L.M.; Mayo Cardiovascular Infections Study Group. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8(11):1678–2685. doi: 10.1016/j.hrthm.2011.05.015

6. Uslan D.Z., Dowsley T.F., Sohail M.R., Hayes D.L., Friedman P.A., Wilson W.R., Steckelberg J.M., Baddour L.M. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin. Electrophysiol. 2010;33(4):407–413. doi: 10.1111/j.1540-8159.2009.02565.x

7. Beurskens N.E.G., Tjong F.V.Y., Dasselaar K.J., Kuijt W.J., Wilde A.A.M., Knops R.E. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: A viable solution? Heart Rhythm. 2019;16(1):66–71. doi: 10.1016/j.hrthm.2018.07.006

8. Dundar C., Tigen K., Tanalp C., Izgi A., Karaahmet T., Cevik C., Erkol A., Oduncu V., Kirma C. The prevalence of echocardiographic accretions on the leads of patients with permanent pacemakers. J. Am. Soc. Echocardiogr. 2011;24(7):803–807. doi: 10.1016/j.echo.2011.03.001

9. Downey B.C., Juselius W.E., Pandian N.G., Estes N.A. 3rd, Link M.S. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Pacing Clin. Electrophysiol. 2011;34(6):679–683. doi: 10.1111/j.1540-8159.2011.03034.x

10. Chang D., Gabriels J., Laighold S., Williamson A.K., Ismail H., Epstein L.M. A novel diagnostic approach to a mass on a device lead. Heart-Rhythm Case Rep. 2019;5(6):306–309. doi: 10.1016/j.hrcr.2019.03.001

11. Salaun E., Deharo J.C., Casalta J.P., Franceschi F., Hubert S., Renard S., Riberi A., Avierinos J.F., Habib G. An oscillating mass attached to a pacemaker lead: Thrombus or vegetation? A fishing story. JACC Clin. Electrophysiol. 2017;3(8):915–916. doi: 10.1016/j.jacep.2016.12.028

12. Demin A.A., Kobalava Zh.D., Skopin I.I., Tyurin P.V., Boytsov S.A., Golukhova E.Z., Gordeev M.L., Gudymovich V.D., Demchenko E.A., Drobysheva V.P., … Shostak N.A. Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2022;27(10):113–192. [In Russian]. doi: 10.15829/1560-4071-2022-5233